Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on GREAT PORTLAND ESTATES PLC. We currently have 4 research reports from 1 professional analysts.
|23Mar17 16:44||RNS||Director/PDMR Shareholding|
|07Mar17 09:15||RNS||Director/PDMR Shareholding|
|06Mar17 17:15||RNS||Holding(s) in Company|
|02Mar17 15:35||RNS||Director/PDMR Shareholding|
|27Feb17 17:02||RNS||Holding(s) in Company|
|10Feb17 07:00||RNS||Great Portland Estates sells Rathbone Square|
|01Feb17 17:08||RNS||Holding(s) in Company|
Frequency of research reports
Research reports on
GREAT PORTLAND ESTATES PLC
GREAT PORTLAND ESTATES PLC
Panmure Morning Note 12-01-16
12 Jan 16
Lettings in 3Q16 have been struck at 17.1% above the March 2015 values and, if the larger deals are excluded the broader investment lets were 27.1% above. This underlines the extraordinary strength of the London commercial property rental market. Markets are very nervous currently and the property sector is likely to be nervous about the impact of geopolitical risks and a potential Brexit on central London occupancy. However, the economy remains very buoyant with Great Portland commenting that no tenants have raised concerns about these issues to date. We believe that the London stocks remain defensive and sheltered from the oil, commodity and currency risks. We retain our BUY recommendation.
Panmure Morning Note 11-11-15
11 Nov 15
The Facebook let at Rathbone Place by Tottenham Court Road Crossrail station has resulted in the recognition of a large tranche of development profit raising the NAV/s strongly, +14% this half year. The results focus on the valuation growth at this stage in the cycle. The group looks to the property cycle to create returns for shareholders and is now well entrenched in the execution phase of its program. The income growth during this phase is more modest as the group has been developing and refurbishing assets. The letting process is now gaining momentum into a strong London office rental market. We raise our target price to 1010p (from 944p) and retain our Buy recommendation.
Panmure Morning Note 14-09-15
14 Sep 15
Great Portland Estates has let office space amounting to 227,324 sqft of its Rathbone Place development to Facebook. The deal provides for additional lets to the group which could increase Facebook's presence in this location, close to the Tottenham Court road Crossrail station to c 350,000 sqft. The deal, at rents overall above ERV, should enable the recognition of some of the development profit in upcoming valuations. After deducting the provision for overage to Royal Mail group, this could still amount to an extra 10p on the valuation. We retain our Buy recommendation and 944p target price.
Panmure Morning Note 08-07-15
08 Jul 15
The management point to a better year than FY15E for rental growth when +10.3% was achieved. The London office market is very strong at present and Great Portland Estates is now monetising the benefits of the development pipeline and asset management program it has been working on. The lettings are delivering over 45% reversions on previous passing levels and recent lets were 13% ahead of June 2014 ERVs. We retain our Buy and 944p target price.
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
28 Mar 17
ClearStar* (CLSU): Building a background for growth (CORP) | Sound Energy (SOU): TE-8 results (HOLD) | LiDCO* (LID): 2017 should be a transformative year (CORP) | Proteome Sciences* (PRM): FY 2016 in line. Moving towards breakeven (CORP) | Fulcrum (FCRM): Significant market potential, rising margins and a strong balance sheet (BUY) | Mortgage Advice Bureau (MAB1): Strong and growing intellectual property (BUY) | 7digital* (7DIG): Open offer result (CORP)
Small Cap Breakfast
23 Mar 17
K3 Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march.